This mdr is created as a follow-up to record (b)(4), initially reported on product code otn asr exemption # e2014015 for oct-november 2017.This mdr is to reflect the additional information to be added to the initial asr report.(patient age and product information).The lot number was reviewed for complaint trend, nonconforming report and capa review.No trends were noted.
|
Additional information, reported to coloplast though not verified stated, information stated on (b)(6) 2009 patient experienced stress incontinence, vaginal leukorrhea and candida vulvovaginitis, incontinence.Information stated between (b)(6) 2011- (b)(6) 2017 patient experienced uti, hematuria, vaginal bleeding, unspecified urinary incontinence, periurethral mesh erosion, vaginal infection, small erosion, urinary retention from bladder floor spasm, sui, erosion, vaginal mesh excision ((b)(6) 2017), cystoscopy, urethrolysis, wound debridement.The patient had an additional aris sling, reported under 2125050-2020-00095.Information did not specify which aris sling the events between 10/21/2011-3/30/2017 were reported for.
|